IL-24 armored CAR19-T cells show enhanced antitumor activity and persistence

Signal Transduct Target Ther. 2021 Jan 14;6(1):14. doi: 10.1038/s41392-020-00380-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Immunotherapy, Adoptive*
  • Interleukins / immunology*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / immunology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Receptors, Chimeric Antigen / immunology*

Substances

  • Interleukins
  • Receptors, Chimeric Antigen
  • interleukin-24